Home Cart 0 Sign in  
X

[ CAS No. 1990-90-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1990-90-5
Chemical Structure| 1990-90-5
Chemical Structure| 1990-90-5
Structure of 1990-90-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1990-90-5 ]

Related Doc. of [ 1990-90-5 ]

Alternatived Products of [ 1990-90-5 ]
Product Citations

Product Citations

William T. McClintic ; Zachary D. Chandler ; Lalitha M. Karchalla , et al. DOI:

Abstract: Botulinum neurotoxin (BoNT) is a potent protein toxin that causes muscle paralysis and death by asphyxiation. Treatments for symptomatic botulism are intubation and supportive care until respiratory function recovers. Aminopyridines have recently emerged as potential treatments for botulism. The clinically approved drug 3,4-diaminopyridine (3,4-DAP) rapidly reverses toxic signs of botulism and has antidotal effects when continuously administered in rodent models of lethal botulism. Although the therapeutic effects of 3,4-DAP likely result from the reversal of diaphragm paralysis, the corresponding effects on respiratory physiology are not understood. Here, we combined unrestrained whole-body plethysmography (UWBP) with arterial blood gas measurements to study the effects of 3,4-DAP, and other aminopyridines, on ventilation and respiration at terminal stages of botulism in mice. Treatment with clinically relevant doses of 3,4-DAP restored ventilation in a dose-dependent manner, producing significant improvements in ventilatory parameters within 10 minutes. Concomitant with improved ventilation, 3,4-DAP treatment reversed botulism-induced respiratory acidosis, restoring blood levels of CO2, pH, and lactate to normal physiologic levels. Having established that 3,4-DAP–mediated improvements in ventilation were directly correlated with improved respiration, we used UWBP to quantitatively evaluate nine additional aminopyridines in BoNT/A-intoxicated mice. Multiple aminopyridines were identified with comparable or enhanced therapeutic efficacies compared with 3,4-DAP, including aminopyridines that selectively improved tidal volume versus respiratory rate and vice versa. In addition to contributing to a growing body of evidence supporting the use of aminopyridines to treat clinical botulism, these data lay the groundwork for the development of aminopyridine derivatives with improved pharmacological properties.

Purchased from AmBeed: ; ; ;

Product Details of [ 1990-90-5 ]

CAS No. :1990-90-5 MDL No. :MFCD01704431
Formula : C6H8N2 Boiling Point : -
Linear Structure Formula :- InChI Key :VGJLGPCXUGIXRQ-UHFFFAOYSA-N
M.W : 108.14 Pubchem ID :74811
Synonyms :

Calculated chemistry of [ 1990-90-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.61
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.13
Log Po/w (XLOGP3) : 0.54
Log Po/w (WLOGP) : 0.98
Log Po/w (MLOGP) : 0.13
Log Po/w (SILICOS-IT) : 1.14
Consensus Log Po/w : 0.78

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.41
Solubility : 4.25 mg/ml ; 0.0393 mol/l
Class : Very soluble
Log S (Ali) : -0.93
Solubility : 12.7 mg/ml ; 0.118 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.99
Solubility : 1.11 mg/ml ; 0.0103 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 1990-90-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1990-90-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1990-90-5 ]
  • Downstream synthetic route of [ 1990-90-5 ]

[ 1990-90-5 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 1990-90-5 ]
  • [ 22280-02-0 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 198
[2] Archiv der Pharmazie (Weinheim, Germany), 290<157>494,509,
  • 2
  • [ 1074-98-2 ]
  • [ 1990-90-5 ]
YieldReaction ConditionsOperation in experiment
95% With palladium 10% on activated carbon; hydrogen In ethanol at 16 - 30℃; for 36 h; Step 2: A solution of 3-methyl-4-nitropyridine /V-oxide (30.0g, 195 mmol) and 10percent Pd-C (6.0 g) in EtOH (450 mL) was stirred at rt under H2 (5 bar) for 36 h. The RM was filtered through a pad of celite™ and the volatiles were removed under reduced pressure to yield the desired compound (20.0 g, 95percent).
83.6% With hydrogen In water; acetic acid for 2.5 h; 3-Methyl-4-nitropyridine 1-oxide (5.85 g) was dissolved in glacial acetic acid (115 mL) and hydrogenated in a Parr hydrogenation apparatus (catalyst: 220 mg Pt02 x 2 H20, 50 psi) at ambient temperature for 2.5 h. Then the catalyst was filtered off and the solvent was evaporated. After addition of 150 mL of water the pH was adjusted to 12 by addition of 2N NaOH. The resulting solution was extracted 10 times with 100 mL of dichloromethane (containing 5 percent methanol). The combined organic phases were dried over anhydrous sodium sulphate and evaporated to give 3.81 g (83.6percent) of 4-amino-3-methylpyridine.
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2002, vol. 21, # 11-12, p. 737 - 751
[2] Patent: WO2015/22073, 2015, A1, . Location in patent: Page/Page column 39
[3] Patent: WO2005/63744, 2005, A2, . Location in patent: Page/Page column 232
[4] Journal of the American Chemical Society, 1954, vol. 76, p. 4184
[5] Pharmaceutical Bulletin, 1956, vol. 4, p. 174,177
[6] Yakugaku Zasshi, 1955, vol. 75, p. 292,294[7] Chem.Abstr., 1956, p. 1808
[8] Journal of Organic Chemistry, 1954, vol. 19, p. 1633,1636[9] Org. Synth. Coll., 1963, vol. Vol. IV, p. 166
[10] Journal fuer Praktische Chemie (Leipzig), 1988, vol. 330, # 1, p. 154 - 158
[11] Journal of the American Chemical Society, 1954, vol. 76, p. 4184
[12] Yakugaku Zasshi, 1955, vol. 75, p. 292,294[13] Chem.Abstr., 1956, p. 1808
  • 3
  • [ 1003-73-2 ]
  • [ 1990-90-5 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2002, vol. 21, # 11-12, p. 737 - 751
[2] Journal of the American Chemical Society, 1954, vol. 76, p. 4184
[3] Yakugaku Zasshi, 1955, vol. 75, p. 292,294[4] Chem.Abstr., 1956, p. 1808
[5] Yakugaku Zasshi, 1955, vol. 75, p. 292,294[6] Chem.Abstr., 1956, p. 1808
[7] Journal of Organic Chemistry, 1954, vol. 19, p. 1633,1636[8] Org. Synth. Coll., 1963, vol. Vol. IV, p. 166
[9] Journal of the American Chemical Society, 1954, vol. 76, p. 4184
  • 4
  • [ 1678-53-1 ]
  • [ 1990-90-5 ]
Reference: [1] Journal of Organic Chemistry, 1959, vol. 24, p. 1008,1010
[2] Journal of the American Chemical Society, 1954, vol. 76, p. 4184
  • 5
  • [ 86847-73-6 ]
  • [ 1990-90-5 ]
Reference: [1] Synthesis, 2009, # 13, p. 2267 - 2277
  • 6
  • [ 108-99-6 ]
  • [ 1990-90-5 ]
Reference: [1] Journal of the Chemical Society, 1948, p. 198
  • 7
  • [ 100383-06-0 ]
  • [ 1990-90-5 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1957, vol. 290, p. 494,508
  • 8
  • [ 110178-76-2 ]
  • [ 1990-90-5 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1957, vol. 290, p. 494,508
  • 9
  • [ 109127-89-1 ]
  • [ 1990-90-5 ]
Reference: [1] Archiv der Pharmazie (Weinheim, Germany), 1957, vol. 290, p. 494,508
  • 10
  • [ 104915-66-4 ]
  • [ 1990-90-5 ]
Reference: [1] Yakugaku Zasshi, 1955, vol. 75, p. 292,294[2] Chem.Abstr., 1956, p. 1808
  • 11
  • [ 1990-90-5 ]
  • [ 1678-53-1 ]
Reference: [1] Journal of the American Chemical Society, 1954, vol. 76, p. 3167
  • 12
  • [ 1990-90-5 ]
  • [ 18227-67-3 ]
YieldReaction ConditionsOperation in experiment
31.3% at 20 - 60℃; for 15 h; 4-Amino-3-methylpyridine (3.00 g) was dissolved with icecooling in concentrated sulfuric acid (36 mL). Then, fuming nitric acid (4,72 g) was added dropwise. After stirring at room temperature for 1 h, the solution was heated at 60 C for 14 hours. After cooling to ambient temperature, the reaction mixture was poured on ice and the resulting solution was adjusted to pH 13 by addition of solid KOH. The precipitate was filtered off, washed with water and dried. Yield: 1. 198 g (31. 3percent) 4-amino-3- methyl-5-nitropyridine.
Reference: [1] Patent: WO2005/63744, 2005, A2, . Location in patent: Page/Page column 232
[2] Nucleosides, Nucleotides and Nucleic Acids, 2002, vol. 21, # 11-12, p. 737 - 751
  • 13
  • [ 1990-90-5 ]
  • [ 97944-43-9 ]
YieldReaction ConditionsOperation in experiment
78% With hydrogen bromide; dihydrogen peroxide In water at 70℃; for 2 h; Example 36 7- (2,4-Dichloro-phenyl)-2-methyl-2H-pyrazolo [4,3-c] pyridine NH2 Me step 1 Br, 97 97 98 99 Me v step step 1 ) ci ci ci C1 100 101 102 NH2 NAC2STEP 1 To a solution of 4-amino-3-picoline (97,10 g, 0.092 mmol) and HBr (50 mL) heated to 70° C was added 15percent H202 (16 mL) over a 1 h period. The reaction mixture was stirred for additional h and poured in ice (100 g). The pH of the solution was adjusted to about 5 with 50percent NAOH and the resulting red precipitate was filtered. The pH was raised to about 9 and the resulting white precipitate was collected by filtration to afford 98 (13.5 g, 78percent theory)
Reference: [1] Patent: WO2005/16892, 2005, A1, . Location in patent: Page/Page column 104
[2] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[3] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[4] Patent: US2013/5705, 2013, A1,
  • 14
  • [ 1990-90-5 ]
  • [ 18232-91-2 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2002, vol. 21, # 11-12, p. 737 - 751
Recommend Products
Same Skeleton Products

Technical Information

• 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Addition of an Amine to a Conjugated Enone • Amides Can Be Converted into Aldehydes • Amine Synthesis from Nitriles • Amine Synthesis from Nitriles • Amines Convert Acyl Chlorides into Amides • Amines Convert Esters into Amides • Azide Reduction by LiAlH4 • Azide Reduction by LiAlH4 • Basicity of Amines • Buchwald-Hartwig C-N Bond and C-O Bond Formation Reactions • Chan-Lam Coupling Reaction • Chichibabin Reaction • Diazotization Reaction • DIBAL Attack Nitriles to Give Ketones • Enamine Formation • Formation of an Amide from an Amine and a Carboxylic Acid • Formation of an Amide from an Amine and a Carboxylic Acid • Hantzsch Pyridine Synthesis • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hofmann Elimination • Hofmann Rearrangement • Hydride Reductions • Hydrolysis of Imines to Aldehydes and Ketones • Imine Formation from Amines and Aldehydes or Ketones • Leuckart-Wallach Reaction • Mannich Reaction • Methylation of Ammonia • Methylation of Ammonia • Nitrosation of Amines • Peptide Bond Formation with DCC • Petasis Reaction • Preparation of Amines • Preparation of LDA • Pyridines React with Grignard or Organolithium Reagents • Reactions of Amines • Reduction of an Amide to an Amine • Reduction of an Amide to an Amine • Reductive Amination • Reductive Amination • Ring Opening of Azacyclopropanes • Ring Opening of Azacyclopropanes • Ring Opening of Oxacyclobutanes • Specialized Acylation Reagents-Vilsmeier Reagent • Strecker Synthesis • Synthesis of 2-Amino Nitriles • Ugi Reaction
Historical Records

Related Functional Groups of
[ 1990-90-5 ]

Amines

Chemical Structure| 43078-60-0

[ 43078-60-0 ]

3,5-Dimethylpyridin-4-amine

Similarity: 0.85

Chemical Structure| 90196-88-6

[ 90196-88-6 ]

3-Isopropylpyridin-4-amine

Similarity: 0.81

Chemical Structure| 1239605-12-9

[ 1239605-12-9 ]

3-Ethynylpyridin-4-amine

Similarity: 0.81

Chemical Structure| 122475-57-4

[ 122475-57-4 ]

4-Amino-2,3-dimethylpyridine

Similarity: 0.81

Chemical Structure| 3731-52-0

[ 3731-52-0 ]

Pyridin-3-ylmethanamine

Similarity: 0.76

Related Parent Nucleus of
[ 1990-90-5 ]

Pyridines

Chemical Structure| 43078-60-0

[ 43078-60-0 ]

3,5-Dimethylpyridin-4-amine

Similarity: 0.85

Chemical Structure| 90196-88-6

[ 90196-88-6 ]

3-Isopropylpyridin-4-amine

Similarity: 0.81

Chemical Structure| 1239605-12-9

[ 1239605-12-9 ]

3-Ethynylpyridin-4-amine

Similarity: 0.81

Chemical Structure| 122475-57-4

[ 122475-57-4 ]

4-Amino-2,3-dimethylpyridine

Similarity: 0.81

Chemical Structure| 3731-52-0

[ 3731-52-0 ]

Pyridin-3-ylmethanamine

Similarity: 0.76

; ;